These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation. van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733 [TBL] [Abstract][Full Text] [Related]
3. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis. Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368 [TBL] [Abstract][Full Text] [Related]
4. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Wentzensen N; Sherman ME; Schiffman M; Wang SS Gynecol Oncol; 2009 Feb; 112(2):293-9. PubMed ID: 19054549 [TBL] [Abstract][Full Text] [Related]
5. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma. Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504 [TBL] [Abstract][Full Text] [Related]
7. Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples. Carestiato FN; Amaro-Filho SM; Moreira MAM; Cavalcanti SMB Mem Inst Oswaldo Cruz; 2018 Dec; 114():e180456. PubMed ID: 30569945 [TBL] [Abstract][Full Text] [Related]
8. Low incidence of microsatellite instability in patients with cervical carcinomas. Rodriguez JA; Barros F; Carracedo A; Mugica-van Herckenrode CM Diagn Mol Pathol; 1998 Oct; 7(5):276-82. PubMed ID: 9990486 [TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853 [TBL] [Abstract][Full Text] [Related]
10. Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women. Zhang L; Hu D; Wang S; Zhang Y; Pang L; Tao L; Jia W Gene; 2020 Jan; 723():144142. PubMed ID: 31589957 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680 [TBL] [Abstract][Full Text] [Related]
12. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663 [TBL] [Abstract][Full Text] [Related]
13. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer. Ahmad A; Raish M; Shahid M; Batra S; Batra V; Husain SA Cancer Biomark; 2017 Jul; 19(4):375-381. PubMed ID: 28453456 [TBL] [Abstract][Full Text] [Related]
14. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence. Wilting SM; Miok V; Jaspers A; Boon D; Sørgård H; Lando M; Snoek BC; van Wieringen WN; Meijer CJ; Lyng H; Snijders PJ; Steenbergen RD Oncotarget; 2016 Jul; 7(28):43805-43819. PubMed ID: 27270309 [TBL] [Abstract][Full Text] [Related]
16. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579 [TBL] [Abstract][Full Text] [Related]
18. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025 [TBL] [Abstract][Full Text] [Related]
19. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization. Bai LX; Wang JT; Ding L; Jiang SW; Kang HJ; Gao CF; Chen X; Chen C; Zhou Q Asian Pac J Cancer Prev; 2014; 15(21):9313-7. PubMed ID: 25422218 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]